Trials / Sponsors / ImCheck Therapeutics
ImCheck Therapeutics
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Phase 1/2a Study of ICT01 Plus Low Dose SC IL-2 in Patients With Advanced Solid Tumors Solid Tumor, Adult | Phase 1 / Phase 2 | 2022-05-04 |
| Active Not Recruiting | First-in-Human Study of ICT01 in Patients With Advanced Cancer Solid Tumor, Adult, Hematopoietic/Lymphoid Cancer | Phase 1 / Phase 2 | 2020-03-05 |